Improved myocardial function with the addition of pinacidil to custadiol

Transplantation

Volumn 74, Issue 12, 2002, Pages 1666-1671

  Ikizler, Murat ^a   Dernek, Sadettin ^a   Sevin, Behçet ^a   Maxey, Thomas S ^b   Kural, Tugrul ^a  

^a ESKISEHIR OSMANGAZI UNIVERSITY   (Turkey)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE MB; HTK SOLUTION; PINACIDIL; POTASSIUM CHANNEL; TROPONIN I;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; HEART FUNCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PRESERVATION; HEART PROTECTION; HEMODYNAMICS; HYPOTHERMIA; ISOLATED HEART; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0037184730     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200212270-00003     Document Type: Article

References (29)

1. Damiano RJ. The electrophysiology of ischemia and cardioplegia. J Cardiac Surg 1995; 10: 101.
2. Drewnowska K, Clemo HF, Baumgarten CM. Prevention of myocardial intracellular edema induced by St. Thomas' Hospital cardioplegic solution. J Mol Cell Cardiol 1991; 23: 215.
3. Cohen NM, Wise AS, Wechsler RJ. Elective cardiac arrest with a hyperpolarizing adenosine triphosphate-sensitive potassium channel opener: A novel form of myocardial protection. J Thorac Cardiovasc Surg 1993; 106: 317.
4. + channel in cardiac muscle. Nature 1983; 305: 147.
5. Maskal SL, Cohen NM, Hsia PW, et al. Hyperpolarized cardiac arrest with a potassium-channel opener, aprikalim. J Thorac Cardiovasc Surg 1995; 110: 1083.
6. Cohen NM, Lederer WJ. Changes in the calcium current of rat heart ventricular myocytes during development. J Physiol 1988; 406: 115.
7. Braunwald E, Kloner RA. The stunned myocardium: Prolonged, postischemic ventricular dysfunction. Circulation 1982; 66: 1146.
8. Jayawant AM, Stephenson ER, Baumgarten CM, et al. Prevention of cell swelling with low chloride St. Thomas' Hospital solution improves post-ischemic myocardial recovery. J Thorac Cardiovasc Surg 1998; 115: 1196.
9. Jayawant AM, Lawton JS, Hsia P, et al. Hyperpolarized cardioplegic arrest with nicorandil: Advantages over other potassium channel openers. Circulation 1997; 96(Suppl): 240.
10. Lawton JS, Harrington GC, Allen CT, et al. Myocardial protection with pinacidil cardioplegia in the blood-perfused heart. Ann Thorac Surg 1996; 61: 1680.
11. Lawton J, Sepic J, Allen C, et al. Myocardial protection with potassium channel openers is as effective as St. Thomas' solution in the rabbit heart. Ann Thorac Surg 1996; 62: 31.
12. Grover GJ, McCullough JR, Henry DE, et al. Anti-ischemic effects of the potassium channel activators pinacidil and cromakalim and the reversal of these effects with the potassium channel blocker glyburide. J Pharmacol Exp Ther 1989; 251: 98.
13. Galinanes M, Shattock MJ, Hearse DJ. Effects of potassium channel modulation during global ischemia in isolated rat heart with and without cardioplegia. Cardiovasc Res 1992; 26: 1063.
14. Barner HB. Blood cardioplegia: A review and comparison with crystalloid cardioplegia. Ann Thorac Surg 1991; 52: 1354.
15. + channel modulator aprikalim (RP 52891): Improved cardioprotection in isolated ischemic rabbit hearts. Can J Physiol Pharmacol 1994; 72: 126.
16. Bretschneider HJ, Hubuer G, Knoll D, et al. Myocardial resistance and tolerance to ischemia. J Cardiovasc Surg 1975; 16: 241,
17. Lichtenstein SV, Salemo TA, Slutsky AS. Pro: Warm continuous cardioplegia is preferable to intermittent hypothermic cardioplegia for myocardial protection during cardiopulmonary bypass. J Cardiothorac Anesth 1990; 4: 279.
18. Jayawant M, Stephenson ER, Damiano RJ. Advantages of continuous hyperpolarized arrest with pinacidil over St Thomas' Hospital solution during prolonged ischemia. J Thorac Cardiovasc Surg 1998; 116: 131.
19. Du ZY, Hicks M, Rainer S. Ischemic preconditioning enhances preservation of the rat heart during prolonged hypothermic storage through activation of K ATP channels. J Heart Lung Transplant 1997; 16: 50.
20. Menasche P, Kevelaitis E, Mouas C, et al. Preconditioning with potassium channel openers. A new concept for enhancing cardioplegic protection? J Thorac Cardiovasc Surg 1995; 110: 1606.
21. Menasche P, Mouas C, Grousset C. Is potassium channel opening an effective form of preconditioning before cardioplegia? Ann Thorac Surg 1996; 61: 1764.
22. Jiminez E, del Nido PJ, Sarin M, et al. Effects of low extracellular calcium on cytosolic calcium and ischemic contracture. J Surg Res 1990; 50: 293.
23. Dorman BH, Hebbar L, Hinton RB, et al. Preservation of myocyte contractile function after hypothermic cardioplegic arrest by activation of ATP-sensitive potassium channels. Circulation 1997; 96: 2376.
24. Sargent CA, Grover GJ, Antonaccio MJ, et al. The cardioprotective, vasorelaxant and electrophysiological profile of the large conductance calcium-activated potassium channel opener NS-004. J Pharmacol Exp Ther 1993; 266: 1422.
25. Quast U, Guillon JM, Cavero I. Cellular pharmacology of potassium channel openers in vascular smooth muscle. Cardiovasc Res 1994; 28: 805.
26. Laxson DD, Homans DC, Dai X, et al. Oxygen consumption and coronary reactivity in postischemic myocardium. Circ Res 1989; 64: 9.
27. Gerhardt W, Ljungdahl L, Herbert AK. Troponin T and CK-MB (mass) in early diagnosis of ischemic myocardial injury. Clin Biochem 1993; 26(4): 231.
28. Bertinchant JP, Larue C, Pernel I, et al. Release kinetics of serum cardiac troponin I in ischemic myocardial injury. Clin Biochem 1996; 29(6):587.
29. Bourge RC, Naftel DC, Costanzo-Nordin MR. Pretransplantation risk factors for death after heart transplantation. J Heart Lung Transplant 1993;12:549.